Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.

× No keyword cloud information.

4 in total

1. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.

Authors: Seung Jin Lee; Jeong Seok Yeo; Haeng Jung Lee; Eun Jung Lee; Seog Young Kim; Se Jin Jang; Jong Jin Lee; Jin-Sook Ryu; Dae Hyuk Moon
Journal: Eur J Nucl Med Mol Imaging Date: 2014-02-22 Impact factor: 9.236

2. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Authors: Esther Mena; Maria Liza Lindenberg; Baris I Turkbey; Joanna Shih; Jean Logan; Stephen Adler; Karen Wong; Wyndham Wilson; Peter L Choyke; Karen A Kurdziel
Journal: Clin Nucl Med Date: 2014-10 Impact factor: 7.794

3. Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (¹⁸F-FLT) PET/CT in Lung Cancer.

Authors: Kalevi Kairemo; Elmer B Santos; Homer A Macapinlac; Vivek Subbiah
Journal: Diagnostics (Basel) Date: 2020-01-06

Review 4. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.

Authors: R Chowdhury; B Ganeshan; S Irshad; K Lawler; M Eisenblätter; H Milewicz; M Rodriguez-Justo; K Miles; P Ellis; A Groves; S Punwani; T Ng
Journal: Br J Radiol Date: 2014-03-06 Impact factor: 3.039

4 in total

18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.

1. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.

2. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

3. Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer.

Review 4. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.

3. Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (¹⁸F-FLT) PET/CT in Lung Cancer.